Our system can take your drug discovery timeline from years to months.
Click to learn more.
We can save most companies around 40% on testing their vaccine candidates. Our tests can confirm negative immunigenocity with a fraction of the trials used in current testing.
Services can be performed at our labs or in yours, or with approved CROs.
NanoCliq’s technology has been vested by scientists at two of the world’s leading research institutions.
NanoCliq vaccine technology helps pharma companies to dramatically reduce R&D cost by shortening the testing required to identify high potential chemical entities, eliminating purification steps and bringing vaccines quickly to human clinical trials.
NanoCliq helps companies find vaccines up to ten times faster and at a fraction of the cost by using a novel new nanoparticle system developed at Georgia Tech.
% cost savings
Using NanoCliq can save 40% or more off your testing budget.
% Time Savings
NanoCliq can take 2 years off of your drug development timeline.
% Chance of Success
The likelihood that partnering with NanoCliq will increase your odds of success.
NY Daily With the U.S. Centers for Disease Control warning that 700,000 people on the island of Puerto Rico will contract the Zika virus by year’s end, America must mount a public health campaign. New CDC Laboratory Test for Zika Virus Authorized for Emergency Use by FDA In response to a request from the[…]
Jimmy Carter announced Sunday that he no longer needs treatment for cancer, less than seven months after revealing he had been diagnosed with melanoma that spread to his brain. ABC News Article
Courtesy: https://twitter.com/hashtag/nanocliq Read more here: Georgia Bio 2015 For more than 13 years, Georgia Bio has presented Georgia’s premier bioscience and medtech conference welcoming 600+ CEOs, senior executives, scientists and public policy officials from Georgia and across the nation. NanoCliq was honored to be the opening speakers for the conference.